2-[(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-phosphanyloxan-4-yl]oxy}-3,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-4-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl phosphinite

Metabolite details

Identifier

FEBUJFMRSBAMES-UHFFFAOYSA-N

InChI Key

FEBUJFMRSBAMES-UHFFFAOYSA-N

IUPAC name

2-[[6-[3,5-dihydroxy-2-(hydroxymethyl)-6-phosphanyloxan-4-yl]oxy-4-[3,5-dihydroxy-6-(hydroxymethyl)-4-phosphanyloxyoxan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

Preferred name

2-[(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-phosphanyloxan-4-yl]oxy}-3,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-4-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl phosphinite

INN name

—

Synonym

—

ChEBI

CHEBI:184545

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• A Combined Proteomic and Metabolomic Strategy for Allergens Characterization in Natural and Fermented <em>Brassica napus</em> Bee Pollen

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Unfermented_vs_Fermented